We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$42.7B
AUM Growth
+$3.67B
(+9.4%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
2,714
New
351
Increased
1,025
Reduced
1,076
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$367M |
| 2 |
Johnson & Johnson
JNJ
|
+$294M |
| 3 |
Fortinet
FTNT
|
+$260M |
| 4 |
General Mills
GIS
|
+$220M |
| 5 |
Rivian
RIVN
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$485M |
| 2 |
Tesla
TSLA
|
+$476M |
| 3 |
Advanced Micro Devices
AMD
|
+$417M |
| 4 |
Coca-Cola
KO
|
+$344M |
| 5 |
Pfizer
PFE
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Consumer Discretionary | 12.61% |
| 3 | Healthcare | 11.89% |
| 4 | Financials | 10.49% |
| 5 | Industrials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Brunswick
BC
$5.13B
| $329K | ﹤0.01% |
3,400
-3,500
| -51% | -$278K |
|
2077
AMES National
ATLO
$271M
| $329K | ﹤0.01% |
15,400
-5,100
| -25% | -$93.3K |
|
2078
CTS Corp
CTS
$1.83B
| $328K | ﹤0.01% |
+7,500
| New | +$302K |
|
|
NNDM
2079
Nano Dimension
NNDM
$316M
| $328K | ﹤0.01% |
136,500
+27,800
| +26% | +$69.9K |
|
|
CWBC
2080
Community West Bancshares
CWBC
$679M
| $326K | ﹤0.01% |
14,600
-2,900
| -17% | -$50.7K |
|
|
ITIC
2081
Investors Title Co
ITIC
$546M
| $324K | ﹤0.01% |
+2,000
| New | +$297K |
|
|
BRFS
2082
DELISTED
BRF SA
BRFS
| $324K | ﹤0.01% |
116,600
-496,800
| -81% | -$1.24M |
|
|
MOR
2083
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $320K | ﹤0.01% |
+32,300
| New | +$237K |
|
2084
TTM Technologies
TTMI
$12B
| $319K | ﹤0.01% |
20,200
+1,200
| +6% | +$16.7K |
|
2085
FS Bancorp
FSBW
$319M
| $318K | ﹤0.01% |
8,600
-3,500
| -29% | -$110K |
|
2086
Riskified
RSKD
$694M
| $318K | ﹤0.01% |
67,900
-78,100
| -53% | -$320K |
|
2087
Superior Group of Companies
SGC
$185M
| $313K | ﹤0.01% |
23,200
-2,100
| -8% | -$21.9K |
|
2088
Recursion Pharmaceuticals
RXRX
$1.59B
| $313K | ﹤0.01% |
+31,700
| New | +$226K |
|
|
PFIE
2089
DELISTED
Profire Energy, Inc
PFIE
| $312K | ﹤0.01% |
172,100
+131,000
| +319% | +$246K |
|
2090
Tower Semiconductor
TSEM
$24.8B
| $311K | ﹤0.01% |
+10,200
| New | +$266K |
|
2091
Kura Oncology
KURA
$800M
| $311K | ﹤0.01% |
21,600
-2,300
| -10% | -$22.6K |
|
|
ONL
2092
Orion Office REIT
ONL
$150M
| $310K | ﹤0.01% |
54,200
+6,100
| +13% | +$31.8K |
|
2093
Astec Industries
ASTE
$1.16B
| $306K | ﹤0.01% |
8,219
+3,300
| +67% | +$122K |
|
|
TARO
2094
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $305K | ﹤0.01% |
7,300
-5,713
| -44% | -$211K |
|
2095
Capital Bancorp
CBNK
$608M
| $303K | ﹤0.01% |
12,500
-3,600
| -22% | -$76K |
|
|
INZY
2096
DELISTED
Inozyme Pharma
INZY
| $301K | ﹤0.01% |
70,700
-25,400
| -26% | -$90.2K |
|
2097
Essent Group
ESNT
$6.08B
| $301K | ﹤0.01% |
5,700
-100
| -2% | -$4.89K |
|
2098
Nurix Therapeutics
NRIX
$2.41B
| $300K | ﹤0.01% |
29,100
+9,900
| +52% | +$67.9K |
|
2099
Exponent
EXPO
$3.24B
| $299K | ﹤0.01% |
+3,400
| New | +$279K |
|
|
WCC
2100
WESCO International
WCC
$16.7B
| $298K | ﹤0.01% |
+1,714
| New | +$257K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, Two Sigma Advisers held 2,714 positions worth $42.7B, up 9.4% from $39B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers withdrew a net $1.56B in Q4 2023, closing 234 positions and reducing 1,076 holdings. Its most notable exit was Palo Alto Networks, an estimated $281M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Two Sigma Advisers opened a new position in Block Inc worth $238M.
- Two Sigma Advisers's largest Q4 2023 buy was Block Inc: 3,076,207 shares worth $238M.
- Two Sigma Advisers added most to Merck in Q4 2023, an estimated $367M increase.
- Two Sigma Advisers's biggest Q4 2023 reduction was Nike, cutting an estimated $485M.
- Two Sigma Advisers fully exited Palo Alto Networks in Q4 2023, selling an estimated $281M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $42.7B portfolio in Q4 2023.
- Two Sigma Advisers opened 351 new positions and closed 234 in Q4 2023.
- Two Sigma Advisers's portfolio value rose 9.4% quarter-over-quarter to $42.7B.
Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.